Atlas Trials

Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn Infants

Clinical trial NCT00516360 · UNKNOWN

Trial details

NCT number
NCT00516360
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Catheterization
Start date
2007-07-01
Primary completion
2008-08-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.